Studies indicate so-called doctor shoppers obtain, on average, 32 prescriptions from 10 different doctors. Moreover, nearly 90% of handwritten opioid prescriptions may contain errors. With the dangerous and illicit activity of doctor shopping having become a pervasive problem, the Drug Enforcement Agency (DEA) set forth Electronic Prescribing for Controlled Substances (EPCS) regulation designed to minimize the use of controlled substances and overdose related to overprescribing. New York state practitioners are already in compliance with the new electronic standard that eliminates paper prescriptions. Many other states are now in process of adopting their own versions of New York's I-STOP. Soon, EPCS ePrescribe will be standard protocol within United States healthcare facilities. The DEA outlines specific requirements to which healthcare providers, pharmacies, and technology vendors must adhere, one being a mandate that prescribers use two-factor authentication when signing electronic prescriptions. CHALLENGE: EPCS compliance, strong authentication, port conservation, and increased efficiency The state legislature has just passed EPCS regulation that mandates all prescribers become compliant within two years. Leadership of a regional health system has directed its IT team to prepare a plan for the looming deadline. KEY BENEFITS of KSI EPCS PRODUCTS: • Compatibility with Imprivata® Confirm ID platform • Embedded Crossmatch™ biometric authentication • Hands-free BLE mobile authentication enabled • Two-factor authentication, meeting DEA requirements • Multiple functions routed through one USB • Minimization of workflow disruption • Reduction of password use and management • Protection against unauthorized access to PHI • Component integration unclutters the desktop • FIPS-201 and HIPAA compliant • Option to layer security with added RFID • Optional LinkSmart® keyboard cleaning button have proven to be expensive, often misplaced, and difficult to manage. Soft tokens present potential security risks and administrative headaches. Along with adoption of the Imprivata® Confirm ID authentication platform to help meet compliance, locating compatible hardware is top priority. The IT team seeks FIPS-201 and HIPAA compliant security peripherals that are compatible with Confirm ID, in order that the DEA's two-factor authentication requirement is met. Thin clients in operation on the vast majority of the health system's desktops present their own challenge - complying with EPCS threatens to make managing limited available ports even more difficult. Examining the bigger picture, the team recognizes that, over time, the hospitals' workstations have become unruly and inefficient. Security peripherals clutter provider workspaces and increasingly go missing. The team dismisses a token solution due to its overall goal of eliminating use of burdensome passwords. Hard tokens The health system needs a comprehensive solution that addresses compliance while gaining efficiencies.

FACTOR 1: KSI embedded BLE supports Confirm ID hands-free mobile authentication KSI embedded BLE used in mobile authentication, combined with integrated FIPS 201 fingerprint biometrics, meet compliance of EPCS two-factor identity modalities ePrescribe is enabled with two-factor identification and the Confirm ID platform FACTOR 2: KSI fingerprint biometrics provides the second required factor of identity The DEA mandates providers use two factors of authentication when signing an electronic prescription KSI hardware and use of Confirm ID puts healthcare in compliance with EPCS Simple, efficient...